Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Lexaria Bioscience (LEXX) Shares Outstanding (2016 - 2026)

Lexaria Bioscience's Shares Outstanding history spans 12 years, with the latest figure at $24.9 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 41.73% to $24.9 million in Q1 2026 year-over-year; TTM through Feb 2026 was $24.9 million, a 41.73% increase, with the full-year FY2025 number at $19.6 million, changed 0.0% from a year prior.
  • Shares Outstanding hit $24.9 million in Q1 2026 for Lexaria Bioscience, up from $22.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for LEXX hit a ceiling of $24.9 million in Q1 2026 and a floor of $6.0 million in Q1 2022.
  • Historically, Shares Outstanding has averaged $13.3 million across 5 years, with a median of $12.4 million in 2024.
  • Biggest five-year swings in Shares Outstanding: changed 0.0% in 2023 and later soared 141.72% in 2024.
  • Tracing LEXX's Shares Outstanding over 5 years: stood at $6.0 million in 2022, then soared by 73.28% to $10.3 million in 2023, then soared by 69.25% to $17.5 million in 2024, then increased by 27.35% to $22.2 million in 2025, then grew by 11.98% to $24.9 million in 2026.
  • Business Quant data shows Shares Outstanding for LEXX at $24.9 million in Q1 2026, $22.2 million in Q4 2025, and $19.6 million in Q3 2025.